Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:579-584
Published online before print July 30, 2007, doi: 10.1161/HYPERTENSIONAHA.107.091603
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
50/3/579    most recent
HYPERTENSIONAHA.107.091603v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wyrwoll, C. S.
Right arrow Articles by Waddell, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wyrwoll, C. S.
Right arrow Articles by Waddell, B. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DEXAMETHASONE
Medline Plus Health Information
*Steroids
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Other hypertension

(Hypertension. 2007;50:579.)
© 2007 American Heart Association, Inc.


Original Articles

Developmental Programming of Renal Glucocorticoid Sensitivity and the Renin-Angiotensin System

Caitlin S. Wyrwoll; Peter J. Mark; Brendan J. Waddell

From the School of Anatomy and Human Biology, University of Western Australia, Nedlands, Perth, Australia.

Correspondence to Brendan J. Waddell, School of Anatomy and Human Biology, University of Western Australia, Nedlands, Perth, Western Australia 6009, Australia. E-mail bwaddell{at}anhb.uwa.edu.au

Fetal glucocorticoid excess leads to subsequent adult hypertension, but the mechanisms involved in this developmental programming remain largely unknown. In this study we tested the hypothesis that programmed hypertension in rats is linked to altered renal expression of the glucocorticoid receptor, mineralocorticoid receptor, and 11ß-hydroxysteroid dehydrogenase type 2 and components of the intrarenal and adipose renin-angiotensin system. The interactive effects of a postnatal diet enriched in omega-3 fatty acids, which prevents emergence of the hypertensive phenotype, were also examined. Maternal dexamethasone (0.75 µg/mL of drinking water from day 13 to term) markedly increased renal expression of the glucocorticoid receptor in 6-month-old offspring, and this was associated with hypomethylation of the glucocorticoid receptor promoter; renal MR was unaffected. In contrast, maternal dexamethasone reduced renal 11ß-hydroxysteroid dehydrogenase type 2 in offspring, but this effect was prevented by a high omega-3 diet. Consistent with these effects, renal Na/K-ATPase-{alpha}1 was elevated in offspring of dexamethasone-treated mothers, but only in those raised on the standard diet. Maternal dexamethasone also programmed increased expression of renal and adipose angiotensin-converting enzyme and renal renin, but among these changes, only that of renal angiotensin-converting enzyme was prevented by the omega-3 diet. Our data support the hypothesis that programmed hypertension is mediated, in part, by increased renal glucocorticoid sensitivity, with consequent stimulatory effects on Na/K-ATPase-{alpha}1 and intrarenal renin-angiotensin system components. Partial prevention of programmed changes in renal gene expression by postnatal dietary omega-3 fatty acids provides insight into how this intervention prevents hypertension induced by fetal glucocorticoid excess.


Key Words: prenatal programming • hypertension • glucocorticoids • 11ß-hydroxysteroid dehydrogenase type 2 • renin-angiotensin system • kidney • omega-3 fatty acids




This article has been cited by other articles:


Home page
Exp PhysiolHome page
A. L. Fowden and A. J. Forhead
Hormones as epigenetic signals in developmental programming
Exp Physiol, June 1, 2009; 94(6): 607 - 625.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Nguyen Dinh Cat, A. Ouvrard-Pascaud, F. Tronche, M. Clemessy, D. Gonzalez-Nunez, N. Farman, and F. Jaisser
Conditional Transgenic Mice for Studying the Role of the Glucocorticoid Receptor in the Renal Collecting Duct
Endocrinology, May 1, 2009; 150(5): 2202 - 2210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. S. Gilbert and M. J. Nijland
Sex differences in the developmental origins of hypertension and cardiorenal disease
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1941 - R1952.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. A. Armitage, S. Gupta, C. Wood, R. I. Jensen, A.-M. Samuelsson, W. Fuller, M. J. Shattock, L. Poston, and P. D. Taylor
Maternal dietary supplementation with saturated, but not monounsaturated or polyunsaturated fatty acids, leads to tissue-specific inhibition of offspring Na+,K+-ATPase
J. Physiol., October 15, 2008; 586(20): 5013 - 5022.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. S Wyrwoll, P. J Mark, T. A Mori, and B. J Waddell
Developmental programming of adult hyperinsulinemia, increased proinflammatory cytokine production, and altered skeletal muscle expression of SLC2A4 (GLUT4) and uncoupling protein 3
J. Endocrinol., September 1, 2008; 198(3): 571 - 579.
[Abstract] [Full Text] [PDF]